COVID-19 has become a great burden of the world in respect of health care, social, and
economical reason. Several million people died worldwide so far and more and more …

The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory
syndrome coronavirus 2 triggered a global pandemic where control is needed through …

Remdesivir (RDV) is a broad-spectrum antiviral drug, now approved by Regulatory
Agencies for COVID-19 treatment. RDV is associated with improvements in clinical …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta and
Omicron variants have become the dominant variants worldwide, and studies focused on …

Acute respiratory distress syndrome (ARDS) is characterized by noncardiogenic pulmonary
edema. It has a high mortality rate and lacks effective pharmacotherapy. With the outbreak of …

Ischemia-reperfusion-induced (I/R) renal damage is a pathogenic process that starts with
ischemia, then progresses through oxidative stress and inflammation. Tocilizumab (TCZ), a …

SUMMARY COVID-19 is an unpredictable infectious disease caused by SARS-CoV-2. The
development of effective anti-COVID-19 vaccines has enormously minimized the risk of …

The COVID-19 pandemic demanded that many governments implement a comprehensive
lockdown to control the spread of the disease. Several people sought self-care intervention …

Currently, the world needs health-literate citizens who are able to make informed decisions
about COVID-19 and other diseases. Here, we propose a COVID-19 roadmap consisting of …

El propósito de esta guía, a pesar de la abundante bibliografía sobre el tema, es
proporcionar al médico en el ejercicio diario de su tarea, una herramienta de uso sencillo …